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ABSTRACT 24 
The rapid rise of antibiotic resistance has renewed interest in phage therapy – the use of bacteria-25 
specific viruses (phages) to treat bacterial infections. Even though phages are often pathogen-26 
specific, little is known about the efficiency and eco-evolutionary outcomes of phage therapy in 27 
polymicrobial infections. We studied this experimentally by exposing both quorum sensing (QS) 28 
signalling PAO1 and QS-deficient lasR Pseudomonas aeruginosa genotypes (differing in their 29 
ability to signal intra-specifically) to lytic PT7 phage in the presence and absence of two bacterial 30 
competitors: Staphylococcus aureus and Stenotrophomonas maltophilia – two bacteria commonly 31 
associated with P. aeruginosa in polymicrobial cystic fibrosis lung infections. Both the P. 32 
aeruginosa genotype and the presence of competitors had profound effects on bacteria and phage 33 
densities and bacterial resistance evolution. In general, competition reduced the P. aeruginosa 34 
frequencies leading to a lower rate of resistance evolution. This effect was clearer with QS-35 
signalling PAO1 strain due to lower bacteria and phage densities and relatively larger pleiotropic 36 
growth cost imposed by both phage and competitors. Unexpectedly, phage selection decreased the 37 
total bacterial densities in the QS-deficient lasR pathogen communities, while an increase was 38 
observed in the QS-signalling PAO1 pathogen communities. Together these results suggest that 39 
bacterial competition can shape the eco-evolutionary outcomes of phage therapy. 40 
 41 
Keywords: Competition, coevolution, cost of resistance, host-parasite interactions, phage therapy, 42 
polymicrobial infections, quorum sensing signalling, resistance 43 
 44 
 45 
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1. INTRODUCTION 48 
Growing concern for the evolution of antibiotic resistant bacteria and in particular for multi-49 
resistant gram-negative bacteria (Levy and Marshall 2004), has led to renewed interest in alternative 50 
treatments including phage therapy (Rossolini et al. 2014). Phage therapy - the use of pathogen-51 
specific parasitic viruses (bacteriophages) as a treatment for bacterial infections - is almost hundred 52 
years old and has been used for decades to treat bacterial infections in Eastern European countries 53 
such as Georgia and Poland (Alisky et al. 1998; Housby and Mann 2009; Abedon et al. 2011). 54 
While many studies have demonstrated the safety and benefits of phage therapy (Merabishvili et al. 55 
2009; Abedon et al. 2011; Rose et al. 2014) phages have not yet been incorporated into western 56 
medicine partly due to lack of proper clinical trials and historically inconsistent treatment results 57 
(Kutateladze and Adamia 2008). While large-scale clinical trials are currently under way (e.g. 58 
Phagoburn; (Expert round table on and re-implementation of bacteriophage 2016)), the evolutionary 59 
outcomes of phage therapy are relatively unknown. Recent studies have shown that bacteria and 60 
phages can rapidly coevolve during model phage-therapy treatments (Betts et al. 2013; Friman et al. 61 
2016) and that the diversity of phage communities can affect the bacterial resistance evolution (Hall 62 
et al. 2012; Betts et al. 2016). Besides rapid coevolution, further complications could arise from 63 
interspecific bacterial competition due to polymicrobial nature of bacterial infections: many human 64 
infections contain multiple different pathogenic bacterial and other microbial species (Peters et al. 65 
2012). Considerable genotypic variation also exists between different strains of a pathogen and this 66 
variation is known to differ between different patients and to affect the pathogen susceptibility to 67 
phages (Debarbieux et al. 2010; Essoh et al. 2013; Friman et al. 2013). Understanding the relative 68 
importance and interactive effects of these potentially complicating factors is thus crucial for 69 
developing reliable and consistent phage therapy treatments. Here we focused explicitly on the 70 
ecological and evolutionary outcomes of phage therapy in polymicrobial communities and asked 71 
how focal bacterial genotype and the competition with other bacterial pathogens affect the total 72 
bacterial loads and focal pathogen resistance evolution during in vitro model phage therapy.  73 
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 The bacterium Pseudomonas aeruginosa is an opportunistic pathogen that commonly infects many   74 
immunocompromised patients including cystic fibrosis (CF) and burn victim patients (Harrison 75 
2007; Turner et al. 2014). P. aeruginosa is often characterised by multi-drug resistance to 76 
conventional antibiotics (Strateva and Yordanov 2009), and hence, the development of novel phage 77 
therapy treatments could potentially help a large number of patients (Harper and Enright 2011). 78 
While P. aeruginosa can rapidly evolve resistance to various bacteriophages, which could decrease 79 
the feasibility and long-term benefits of phage therapy (Hall et al. 2012; Betts et al. 2013; Friman et 80 
al. 2013), it has also been shown that phages can counteract resistance evolution by coevolving to 81 
be more infective (Betts et al. 2016; Friman et al. 2016). However, it is less clear how important 82 
these coevolutionary dynamics are in more complex microbial communities. For example, lung and 83 
wound infections are often very diverse and consist of multiple different non-pathogenic and 84 
pathogenic bacterial species (Harrison 2007; Folkesson et al. 2012; Korgaonkar et al. 2013) that 85 
could modify phage effects indirectly via competition.   86 
Competition could affect the evolution of phage resistance via demographic and genetic 87 
effects. Firstly, competition is likely to reduce focal pathogen population densities which could 88 
weaken the selection for resistance due to less frequent phage-bacteria encounter rates and lowered 89 
supply of resistance mutations (Levin and Bull 2004; Lopez-Pascua and Buckling 2008). These 90 
demographic effects could be occurring indirectly via competition for shared resources in the site of 91 
infection or directly via interference competition via bacteria-specific toxins such as bacteriocins 92 
(Inglis et al. 2009; Ghoul et al. 2015). Furthermore, P. aeruginosa has been shown to display greater 93 
virulence, antibiotic tolerance and growth when co-cultured with gram-positive S. aureus bacterium 94 
(Korgaonkar et al. 2013; Michelsen et al. 2014), which suggests that the presence of other bacterial 95 
species could also facilitate target pathogen coexistence in polymicrobial infections. Secondly, there 96 
might be trade-offs between evolving phage resistance and retaining competitive ability or virulence 97 
due to conflicting selection pressures (Friman and Buckling 2014). Such trade-offs are often 98 
manifested as antagonistic pleiotropy where a mutation in the gene that confers benefit in the 99 
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presence of phage has a negative effect on some other function such as uptake of nutrients (Lenski 100 
and Levin 1985). The magnitude of such trade-offs is often dependent on environmental conditions, 101 
being larger in nutrient-poor environments (Yoshida, Hairston, and Ellner 2004) or in the presence 102 
of competitors (Kassen 2002). Lastly, it has been shown that the presence of a phage can change the 103 
competitive interactions between different bacterial species and that this effect depends on which 104 
competing bacterial species is affected by the phage (Harcombe and Bull 2005). 105 
 The effect of competitors on focal pathogen fitness, and pathogen potential to evolve 106 
resistance to phages, could further depend on the focal pathogen genotype. For example, P. 107 
aeruginosa CF lung infections are genetically diverse and this heterogeneity is driven by both 108 
temporal (Marvig et al. 2014) and spatial variation (Jorth et al. 2015). It has been recently shown 109 
that phages can have a different effect on P. aeruginosa density and resistance evolution depending 110 
on the strain and the genotype; specifically, the time bacteria spent adapting to the lung environment 111 
seem to make bacteria more susceptible to phages (Friman et al. 2013; Friman et al. 2016). One 112 
notable adaptation to the CF lung environment is the loss of quorum sensing related traits (Marvig 113 
et al. 2014; Michelsen et al. 2014; Andersen et al. 2015). Quorum sensing (QS) is a means by which 114 
bacteria communicate through the release of signalling molecules allowing cells to carry out 115 
density-dependent gene expression (Miller and Bassler 2001). In P. aeruginosa, the ability to 116 
quorum sense is critical for controlling behaviours such as the production of virulence factors 117 
(Folkesson et al. 2012) and it is known that strains from acute infections (early colonisations) are 118 
more virulent compared to strains from chronic infections (long-term colonisations) (Smith et al. 119 
2006; Marvig et al. 2014). Interestingly, recent evidence suggests that QS-regulated genes can also 120 
affect bacterial resistance to phages. For example, with E. coli, QS genes regulate resistance to 121 
phage plastically via reduction of cell surface receptors (Hoyland-Kroghsbo, Maerkedahl, and 122 
Svenningsen 2013; Taj et al. 2014). Similarly, QS has been shown to be an important ‘switch’ for 123 
choosing between different anti-phage defence strategies in the bacterium Vibrio anguillarum (Tan, 124 
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Svenningsen, and Middelboe 2015). As a result, the decrease of phage resistance in P. aeruginosa 125 
QS-mutants could be due to the loss of functional QS-genes.  126 
 Here we used in vitro experimental evolution approach to study the eco-evolutionary 127 
outcomes of phage therapy with P. aeruginosa focal pathogen, that frequently co-infects the lungs 128 
of CF patients (Harrison 2007). We manipulated both the presence of Staphylococcus aureus and 129 
Stenotrophomonas maltophilia competitors (one or two competitors present - our definition of a 130 
polymicrobial community from here on) and the PT7 phage, and used two P. aeruginosa pathogen 131 
genotypes: QS-signalling PAO1 strain and QS-deficient lasR mutant strain, which does not produce 132 
or respond to QS-signals (Diggle et al. 2007). These bacterial species were chosen because they 133 
commonly coexist and infect humans patients suffering from burn wounds or cystic fibrosis (CF) 134 
lung infections (Harrison 2007). We used fully factorial design where both P. aeruginosa genotypes 135 
were evolved in all possible combinations and measured bacterial and phage densities and 136 
coevolutionary changes between P. aeruginosa and PT7 phage at the end of the selection 137 
experiment. We hypothesised that the rate of phage resistance evolution could be negatively 138 
affected by competition via negative effects on population densities (lowered mutation supply rate 139 
and phage-bacteria encounter rates) and that the effect of competition could further depend on the 140 
focal pathogen genotype, the composition of competitor community, and the pleiotropic costs of 141 
adaptation. 142 
 143 
2. MATERIALS AND METHODS 144 
Bacterial and phage strains  145 
In addition to Pseudomonas aeruginosa (Diggle et al. 2007), we used Staphylococcus aureus subsp. 146 
aureus (DSM-20231) and Stenotrophomonas maltophilia (DSM-50170) bacteria in our 147 
experiments. We chose P. aeruginosa as our focal species as it is one of the most common causes of 148 
morbidity for CF patients, while S. aureus and S. maltophilia often coexist with P. aeruginosa 149 
among Haemophilus influenza, Streptococcus pneumoniae, Burkholderia cenocepacia, Ralstonia 150 
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and Achromobacter (Jelsbak et al. 2007; Folkesson et al. 2012). To compare the effect of pathogen 151 
genotype, two strains of Pseudomonas aeruginosa were used: QS-signalling PAO1 and QS-152 
deficient PAO1 lasR mutant strains (Diggle et al. 2007). Apart from the mutation in QS-signalling 153 
pathway, the two isolates were otherwise isogenic (Fletcher et al. 2007). The lasR mutation is often 154 
associated with isolates from the later stages of long-term infections in CF patients (Marvig et al. 155 
2014; Andersen et al. 2015) and its weakened virulence is due to inability to detect and produce 156 
quorum sensing signalling molecules that activate the expression of P. aeruginosa virulence factors 157 
(Smith et al. 2006). A lytic bacteriophage, PT7, which obligately kills P. aeruginosa, was used as a 158 
phage (Friman et al. 2016). Relatively little is known about PT7 phage. Even though its genome has 159 
not been sequenced, previous studies suggest that it is not closely related to PB1-like or phiKMV-160 
like phages (Merabishvili et al. 2007). Similarly, it is unclear which receptors it uses to infect P. 161 
aruginosa. Prior the experiment, we confirmed that phage PT7 was not able to infect S. aureus or S. 162 
maltophilia (tested with streak assays), and that the presence of S. aureus or S. maltophilia had no 163 
effect on phage densities during short-term co-cultivation (24h). Moreover, both the PAO1 and lasR 164 
strains were susceptible to phage PT7 in the beginning of the experiment (streak assays) yielding 165 
similar phage population densities (phage efficiency of plating with plaque essay: ~10
8 
phage 166 
particles mL
-1 
from the same ancestral phage stock). 167 
 168 
Experimental design, growth conditions and selection experiment 169 
We used a factorial design to independently manipulate bacterial community composition, the 170 
presence of phage and P. aeruginosa genotype. To this end, P. aeruginosa focal pathogen strains, 171 
PAO1 and lasR, were evolved in both the absence and presence of phage under four different 172 
competition treatments: alone, with S. aureus, with S. maltophilia and with both S. aureus and S. 173 
maltophilia. Each treatment (16 in total) was replicated five times.  174 
 The communities were grown in 1.5 mL of 10% nutrient broth (NB) media (containing 0.5g 175 
peptone and 0.3g beef extract per litre distilled water) in deep 96-well plates (Starlab; 2.2 mL of 176 
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total volume). All treatments were inoculated with approximately 3.8 × 10
5
 bacterial cells per mL, 177 
where two-competitor treatments were inoculated with 1:1 ratio of both bacteria and three-178 
competitor treatments with 1:1:1 ratio of every bacteria. Approximately 1.5 × 10
8 
phage particles 179 
were added to all phage treatments. All populations were incubated as static cultures at 37°C to 180 
reflect human body temperature. The selection experiment was run for 16 days with transfers 181 
carried out every fourth day. At each transfer, the cultures were first mixed and homogenised using 182 
a pipette before an inoculum of 250 µL was transferred to new deep-well plates containing 1.5 mL 183 
fresh media in each well, after 500 µL of each microbial community was cryopreserved in 20% of 184 
glycerol at -80°C. Given nutrient broth concentration was chosen to allow prolonged growth during 185 
4-day transfer intervals and to reduce the P. aeruginosa biofilm and exopolymer production. 186 
 187 
Bacterial and phage density measurements 188 
Bacterial densities were measured only at the end of the experiment by serially diluting the samples 189 
isolated from the last time point and plating out 10µl of each dilution onto NB agar plates (100% 190 
NB media supplemented with 12g agar per litre). To determine P. aeruginosa densities in multi-191 
species communities, community treatment samples were also plated on Pseudomonas selective 192 
agar plates (16g Peptic digest of animal tissue, 10g Casein enzymic hydrolysate, 10g K2SO4, 1.4g 193 
MgCl2 • 6H2O, 10ml glycerol and 11g Agar per litre with 200mg C-N selective supplement 194 
dissolved in 4ml 1:1 ethanol:distilled water). Bacteria were incubated at 37°C for 48 hours before 195 
counting the colonies and calculating the number of colony forming units (CFU) per ml. At every 196 
transfer, phages were extracted by mixing with 10% chloroform to kill the bacteria. After vortexing 197 
and centrifugation, chloroform-free phage supernatants were stored at 4°C. Phage densities were 198 
estimated at every transfer with plaque assays where phage densities are defined as growth on a 199 
lawn of ancestral PAO1 bacterial strain.  PAO1 ancestral strain was grown at 37°C for 24hours and 200 
200µl of this culture was then mixed with 20ml of 50°C soft agar and poured in an even overlay 201 
over square NB agar plates. A 10µl of phage serial dilutions (10
-4
 – 10
-7
) was then pipetted onto the 202 
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surface of the pseudomonas-agar overlay, plates were incubated at 37°C for 24 hours, and the 203 
number of phage plaques, i.e. phage particles, counted. 204 
 205 
Phage resistance assays 206 
A streak assay methodology was used to estimate the evolution of bacterial resistance and phage 207 
infectivity (Buckling and Rainey 2002). 12 randomly chosen colonies per each P. aeruginosa 208 
population were isolated at the end of the experiment and grown in 96-well microplates at 37°C in 209 
150µl of NB media. After 24-hour growth, colonies were cryopreserved at -80°C as above for 210 
evolutionary analyses. Phage resistance was measured by pipetting 25µl of phage in a line across 211 
square NB plates. A sterilised 12-pin replicator (V&P Scientific) was then used to streak 12 212 
bacterial colonies across the dried line of phage. Plates were incubated at 37°C for 24 hours (or 213 
until the bacterial streak became visible). Colonies with a clear reduction in growth over the phage 214 
line were scored as susceptible (0) and with normal growth over the phage as resistant (1). Phage 215 
resistance was determined at the population level in terms of a proportion of resistant colonies per 216 
population. All P. aeruginosa colonies were tested against the ancestral PT7 phage and evolved PT7 217 
phages isolated from their own population (coevolved phage population isolated by the way of 218 
chloroforming as described above).  219 
 220 
Measuring the pleiotropic cost of adaptation 221 
The pleiotropic cost of adaptation was measured as the final bacterial density at 48h by using the 222 
same colonies that were used in the phage resistance assays. Colonies were inoculated in 96-well 223 
microplates containing 200µl NB media per well by using a sterilised 96-pin replicator (Boenik). 224 
The plates were then grown at 37°C and optical density (OD600) measurements taken after 48 hours. 225 
The growth of the colonies, which had been subjected to competition and or phages in the selection 226 
experiment was compared to colonies that had evolved alone. A mean population density was 227 
calculated for all the colonies isolated from the same population. Even though this method results in 228 
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indirect fitness measures it was the only practical way to estimate the cost due to a high number of 229 
evolved clones (960 clones). 230 
 231 
Statistical analysis 232 
All models and test statistics are presented in the supplementary tables 1-5. For the bacterial density 233 
data, a linear model was fitted predicting square root transformed P. aeruginosa density as a 234 
function of phage treatment, competition and pathogen genotype. For the phage density data, a 235 
mixed model was used for log transformed phage density data as a function of competition and 236 
pathogen genotype with time set as a repeated factor. For the phage resistance data, a linear model 237 
was fitted predicting arsin transformed resistance data as a function of phage evolution (ancestral or 238 
coevolved), pathogen genotype, and competition. A similar model was used for data predicting the 239 
cost of adaptation with the exception that untransformed bacterial growth data was used for the 240 
analysis. Post hoc tukey honest significance difference tests were carried out to further investigate 241 
significant interactions between factor levels. All analyses were conducted in R, version 3.1.2. 242 
(Team. 2014). 243 
3. RESULTS 244 
Bacterial and phage densities during the selection experiment 245 
Both phages (F1, 64 = 8.67, p=0.005) and competitors (F3, 64 = 48.80, p<0.001) significantly reduced 246 
P. aeruginosa densities in the end of the selection experiment (Fig. 1a-b, Supplementary Table 1). In 247 
the absence of phages, both PAO1 and lasR monocultures had higher P. aeruginosa densities 248 
compared to all polymicrobial communities, and PAO1 strain reached higher population densities 249 
compared to lasR strain when evolving in the absence of a phage and competitors (p<0.001 for all 250 
comparisons). However, the relative effect of competition was stronger for the PAO1 strain 251 
(genotype × competition:  F3, 64 = 5.02, p=0.003). Moreover, phages reduced the densities of PAO1 252 
strain more compared to a lasR strain (phage × competition: F3, 64 = 7.70, p<0.001). The phage 253 
effect depended also on the type of competitive community: in general, phage had a negative effect 254 
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on P. aeruginosa in the presence of S. aureus regardless of the pathogen genotype, while phages had 255 
mainly non-significant effects in the other polymicrobial communities (and even a positive effect in 256 
the presence of S. maltophilia, Fig. 1a-b). Unexpectedly, phage selection also affected the total 257 
bacterial biomasses in the polymicrobial communities (Fig. 1c, supplementary table 2) by 258 
increasing the total bacterial densities in the PAO1 communities, and decreasing the total bacterial 259 
densities in the lasR communities in general (genotype × phage: F1, 56 = 8.04, p=0.006; the effect 260 
varied depending on the community composition, supplementary figure 1).  261 
 Phage densities decreased during the selection experiment in general (Time: F3, 30.35 = 17.34, 262 
p<0.001, Fig. 2a-b, Supplementary table 3). While competition had no significant main effect on the 263 
phage densities, a significant interaction was found: even though competition had no effect in the 264 
weakly virulent pathogen communities, it reduced the phage densities in the PAO1 pathogen 265 
communities (genotype × competition: F1, 32.1 = 2.96, p=0.047, Fig. 2a-b). The number or type of 266 
competitors did not affect the phage densities with either PAO1 or lasR strain (p>0.05 in all 267 
comparisons). Together these results suggest that competitors had stronger negative effects on both 268 
the bacteria and phages in the PAO1 compared to lasR pathogen communities. 269 
 270 
Bacteria-phage coevolution in different communities 271 
Both initially susceptible PAO1 and lasR strains evolved increased levels of resistance to ancestral 272 
phage (Fig. 3a-b, supplementary table 4), while the lasR strain evolved higher levels of resistance 273 
compared to the PAO1 strain in general (genotype: F1, 62 = 35.94, p<0.001). While competitors had 274 
no effect on the lasR strain resistance evolution, they generally constrained PAO1 resistance 275 
evolution (phage origin × competition: F1, 62 = 6.94, p<0.001) with all competitive communities 276 
having similar effects (p>0.05 in all comparisons). We also found that phages coevolved to become 277 
more infective during the selection experiment (Fig. 3a-b): the resistance of evolved bacteria was 278 
lower when measured against evolved compared to ancestral phages (phage origin: F1, 62 = 25.38 279 
p<0.001). Interestingly, PAO1 resistance was less affected by phage coevolutionary history 280 
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(ancestral vs. coevolved) compared to lasR strain (phage origin × genotype: F1, 62 = 4.15, p=0.046). 281 
Together these results suggest that competition altered the trajectory of bacteria–phage co-282 
evolution. 283 
 284 
Pleiotropic cost of adaptation 285 
Coevolutionary history with the phage led to reduced bacterial growth in the absence of phages (F1, 286 
71 = 13.36, p<0.001, Fig. 4a-b, Supplementary table 5). While the focal pathogen genotype (F1, 71 = 287 
2.34, p=0.131) or the presence of competitors (F1, 71 = 1.88, p=0.175) had non-significant main 288 
effects on the pathogen growth, the growth cost imposed by phage selection was larger with the 289 
PAO1 strain (genotype × phage: F1, 71=6.27, p=0.015). Moreover, already the presence of 290 
competitors led to reduced PAO1 strain growth in the absence of phage selection (genotype 291 
× competition: F1, 71 = 7.08, p=0.010; all competitive communities had similar effects: F3, 63 = 2.38, 292 
p=0.078). Consistent with the population density data, the evolved PAO1 strain reached higher 293 
population densities compared to lasR strain when bacteria had evolved in the absence of a phage 294 
and competitors (genotype × phage: F1, 71=6.27, p=0.015). These results suggest that even though 295 
both pathogen genotypes suffered from a reduced growth due to phage selection in monocultures, 296 
only the PAO1 strain was affected by the presence of competitors and hence suffered relatively 297 
higher pleiotropic cost of adaptation in polymicrobial communities. 298 
 299 
4. DISCUSSION  300 
Here we studied the role of bacterial competition for the efficiency and eco-evolutionary outcomes 301 
of phage therapy in model polymicrobial infections in vitro. We found that both phages and 302 
competitors reduced the focal pathogen densities. However, this effect was strongly dependent on 303 
the focal pathogen genotype with both competitors and phage having a more severe effect on the 304 
QS-signalling PAO1 strain. The negative effects of competition observed at the population level 305 
correlated with reduced rate of resistance evolution. Interestingly, phage presence decreased the 306 
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total bacterial densities in lasR pathogen communities demonstrating an unexplored potential 307 
benefit of phage therapy: indirect, community-wide reduction in pathogenic bacterial loads in 308 
polymicrobial infections. However, a converse pattern was observed in PAO1 communities, which 309 
suggest that phages could also indirectly worsen the polymicrobial infections by increasing the 310 
density of other pathogenic bacteria.  Together these results suggest that phage-mediated effects 311 
depend on bacterial competition and the focal pathogen genotype pinpointing the need to 312 
understand eco-evolutionary consequences of phage therapy in the community context. 313 
 Both competitors and phage had a negative effect on P. aeruginosa densities while the effect 314 
of competition was relatively larger compared to the effect of a phage. While the number or the 315 
composition of competitive communities had no clear effects on P. aeruginosa densities, the effect 316 
of competition depended on the P. aeruginosa genotype being more severe for the PAO1 compared 317 
to lasR strain in general. This suggests that QS may play an important role for P. aeruginosa 318 
competition against other bacterial species. For example, the proportion of lasR mutants typically 319 
increases during chronic polymicrobial CF-infections (Smith et al. 2006; Marvig et al. 2014; Ghoul 320 
et al. 2015) and this could be potentially partly explained with QS-mediated competitive 321 
interactions with other bacteria (Harrison et al. 2008). There are several mutually nonexclusive 322 
explanations for reduced P. aeruginosa growth in the presence of competitors. First, competition for 323 
limited resources was likely stronger in the presence of other bacterial species leading to lower P. 324 
aeruginosa densities in polymicrobial pathogen communities. Second, interference competition 325 
could have directly reduced P. aeruginosa growth directly. For example, S. maltophilia has been 326 
observed to influence P. aeruginosa biofilm architecture and protein synthesis (Ryan et al. 2008), 327 
while P. aeruginosa has been shown to have negative effects on S. aureus due to upregulation of 328 
antistaphylococcal substances such as pyocyanin and phenazine (Michelsen et al. 2014). Even 329 
though S. aureus has not been shown to have direct negative effects on P. aeruginosa, the S. aureus 330 
presence has been shown to favour the increase in the frequency of QS-deficient mutants (Harrison 331 
et al. 2008). In line with this study, it has been found that a QS-positive PAO1 strain interacts more 332 
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negatively with S. aureus compared to a QS-negative lasR strain (Michelsen et al. 2014). Recent 333 
evidence suggests that reduced antagonism between S. aureus on P. aeruginosa lasR mutants could 334 
be due to metabolic divergence (Frydenlund Michelsen et al. 2015). However, more detailed 335 
community level experiments are needed to understand these dynamics more profoundly. 336 
The negative effect of phage was clearest in PAO1 monoculture and generally in the 337 
presence of S. aureus with both pathogen genotypes. The presence of S. maltophilia did not affect 338 
phage efficiency with the PAO1 strain and even increased the lasR densities in the presence of 339 
phage (Fig. 1a-b), while phage had no effects on P. aeruginosa densities in the presence of both S. 340 
maltophilia and S. aureus. Together these results suggest that phages can reduce P. aeruginosa 341 
densities additively in the presence of competitors but that this effect depends on the strength of 342 
competition and the composition of the competing bacterial community. Interestingly, phage 343 
presence decreased and increased the total bacterial densities of polymicrobial lasR and PAO1 344 
communities, respectively. Reduction in PAO1 frequency by the phage could have led to a 345 
competitive release and increased the growth of S. aureus, S. maltophilia and total bacterial 346 
densities. Conversely, resource competition was likely more intense and more symmetric within 347 
lasR communities due to stronger levels of phage resistance evolution (and hence higher P. 348 
aeruginosa density). Lastly, it has been shown that phage selection can impose relatively higher 349 
competitive cost for the PAO1compared tothe lasR strain due to upregulation of siderophore 350 
production (Vasse, Torres-Barcelo, and Hochberg 2015). Such metabolic cost could also potentially 351 
explain relatively poorer PAO1 growth in the presence of competitors even in the non-social culture 352 
conditions used in this experiment. In addition to demographic explanations, the potential changes 353 
at the gene expression level warrant thus further investigation in the future.  354 
 In line with the bacterial density data, the phage abundances were also generally 355 
lower in the presence of competitors and this effect was clearer with the PAO1 strain that suffered 356 
more heavily from competition compared to the lasR strain. Competition-mediated reduction in 357 
bacterial and phage densities correlated with reduced levels of resistance evolution, and as a result, 358 
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PAO1 strain evolved lower levels of resistance compared to the lasR strain. Simple demographic 359 
effects that weaken the strength of selection via reduced bacteria and phage encounter rates and 360 
lowered mutation supply rate (Lopez-Pascua and Buckling 2008) could thus be important for the 361 
evolutionary outcomes of phage therapy in polymicrobial infections. We also found that phages 362 
coevolved to be more infective during the selection experiment as demonstrated by higher levels of 363 
resistance of evolved bacteria to the ancestral compared to evolved phage populations. In line with 364 
the population dynamics data, the coevolutionary signal was stronger in lasR pathogen communities 365 
where both bacterial and phage densities were also higher. Bacterial competition did not thus 366 
constrain only the bacterial resistance but also the phage infectivity evolution and the trajectory of 367 
phage-bacteria coevolution.   368 
Also, some underlying genetic differences could have affected PAO1 and lasR strain 369 
response to phages. It has been shown that removing, altering and concealing cell surface receptors 370 
can prevent phage adsorption (Seed 2015) and that a functional QS system is important for 371 
regulating such phage defences (Hoyland-Kroghsbo, Maerkedahl, and Svenningsen 2013; Taj et al. 372 
2014; Tan, Svenningsen, and Middelboe 2015). In contrast to these findings, we found that QS-373 
defective strains were able to evolve higher levels of resistance to phages especially in the presence 374 
of bacterial competitors. A similar pattern has been found before, where the loss of QS impaired 375 
bacterial twitching motility leading to elevated resistance to pili-specific phages (Glessner et al. 376 
1999). Even though the PT7 target receptor is unknown, both the PAO1 and lasR strains were 377 
equally susceptible to the phage in the beginning of the experiment. This suggests that initial 378 
differences in PAO1 and lasR strains’ QS ability unlikely drove the long-term differences in the 379 
bacterial resistance and phage infectivity evolution. Phage receptors are also often important for 380 
other purposes including nutrient uptake (Lenski and Levin 1985), and hence, mutations in phage 381 
receptors often reduce bacterial competitive ability. In support for this, we found that both evolved 382 
PAO1 and lasR monoculture strains suffered reduced growth in the absence of phages and 383 
competitors if they had evolved in the presence of a phage during the selection experiment. 384 
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Interestingly, while competitors increased the magnitude of the growth cost with PAO1 strain, 385 
competitors had no effect or even a positive effect on lasR growth. One explanation for this is that 386 
less antagonistic interactions between the lasR and competitors allowed more rapid accumulation of 387 
compensatory mutations during the selection experiment due to relatively large population size and 388 
mutation supply rate compared to PAO1 strain. We also found that evolved PAO1 strain grew better 389 
in the growth media compared to lasR strain when the bacteria had evolved in the absence of a 390 
phage and competitors. This suggest that functional QS-system could help P. aeruginosa to adapt to 391 
abiotic environmental conditions potentially due to depressing of growth-limiting intracellular 392 
metabolism (Asfahl et al. 2015). In the community context our results suggest that even though both 393 
focal pathogen genotypes were able to evolve resistance to phage the PAO1 strain suffered more 394 
severe costs of adaptation due to both competition and phage.  395 
Our results have important implications for the development of phage therapies in the 396 
context of polymicrobial infections. First, selection for phage resistance could be weaker in 397 
polymicrobial communities due to a competition-mediated reduction in the focal pathogen density 398 
and relatively higher pleiotropic costs of adaptation. Competition could thus enhance the phage 399 
efficacy when treating acute CF and burn infections that are commonly co-infected by QS-400 
signalling P. aeruginosa, S. aureus and S. maltophilia (Harrison 2007; Turner et al. 2014). However, 401 
in contrary, P. aeruginosa resistance evolution to phages could be a more severe problem in chronic 402 
polymicrobial CF infections that are often dominated by P. aeruginosa mutants that have lost QS-403 
signalling ability during the long-term adaptation (Smith et al. 2006; Marvig et al. 2014; Andersen 404 
et al. 2015). Interestingly, we found that higher levels of lasR strain resistance evolution were 405 
correlated with the higher rate of phage infectivity evolution, which could open up avenues for pre-406 
adapting phages to be more infective before clinical phage therapy treatments (Betts et al. 2013; 407 
Friman et al. 2016). Moreover, it would be interesting to investigate if our results hold when 408 
multiple phage species are applied as a phage cocktail. We also want note that it is possible that 409 
both S. aureus and S. maltophilia strains evolved during the selection experiment. For example, it is 410 
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known that P. aeruginosa can promote the formation of small colony variants with S. aureus leading 411 
to changes in virulence and antibiotic resistance (Hoffman et al. 2006; Frydenlund Michelsen et al. 412 
2015). It is thus important to expand the study the evolutionary effects of competition and phage 413 
selection across the whole polymicrobial community in the future and also link these phenotypic 414 
changes with the changes at the genotypic level. 415 
In conclusion, here we show that the presence of competitors can modulate the phage-416 
mediated effects on a focal pathogen. Crucially, phage selection imposed weaker selection for 417 
resistance evolution when the effect of competition with the focal pathogen was strong. Moreover, 418 
while the phage presence indirectly reduced the total bacterial loads in weakly virulent lasR 419 
pathogen communities, phages increased the total bacterial densities in highly virulent PAO1 420 
pathogen communities. Bacterial competition is thus likely to be an important factor affecting both 421 
the ecological and evolutionary outcomes of phage therapy in polymicrobial infections. From a 422 
therapeutic perspective, the fact that overwhelming phage numbers were not able to eradicate 423 
Pseudomonas even in the presence of competitors reinforces the importance of studying phage-424 
bacteria interactions in the polymicrobial context.  425 
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FIGURE LEGENDS 586 
 587 
Figure 1. The comparison of P. aeruginosa (panels a and b) and total bacterial population densities 588 
(panel c) in the end of the selection experiment between different treatments (CFU denotes for 589 
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colony forming units per mL). Panel c shows the mean over all competition treatments for PAO1 590 
and lasR strains, respectively. All bars show ±1 s.e.m. 591 
 592 
Figure 2. Phage population densities in PAO1 (panel a) and lasR (panel b) focal pathogen 593 
communities in the absence and presence of competitors (PFU denotes for plaque forming units, 594 
i.e., phage particles per mL). All bars show ±1 s.e.m. 595 
 596 
Figure 3. The resistance of evolved PAO1 (light grey) and lasR (dark grey) strains to ancestral and 597 
coevolved phages measured at the end of the experiment. Competition treatment shows the absence 598 
and presence of competitors during the selection experiment. Only populations that had evolved in 599 
the presence of phage were used for the analysis; all P. aeruginosa populations that had evolved in 600 
the absence of phage were susceptible to phages. All bars show ±1 s.e.m. 601 
 602 
Figure 4. The cost of adaptation measured in terms of maximum population density after 48h of 603 
growth. Panel (a) shows the growth of evolved PAO1 and panel (b) the growth of evolved lasR 604 
strain in the absence of phage or competitors at the end of the selection experiment. Phage and 605 
competition treatments denote the absence and presence of a phage and competitors during the 606 
selection experiment. All bars show ±1 s.e.m. 607 
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